The IRA Is Penalizing Many Cancer Drugs That Work Best

FDA-Approved Autoimmune Drugs Can Kill Small Cell Cancers, UCLA CRISPR Study Finds

Leflunomide and teriflunomide, FDA-approved for arthritis and MS, can kill small cell neuroendocrine cancers of the lung, prostate, and ovary in lab models, UCLA reports in PNAS. A genome-wide CRISPR screen exposed a hidden molecular dependency in these long-untreatable tumors that existing drugs already target.

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

Medication abortion: Decisions from federal courts, the FDA or Trump’s Department of Justice could try to end access via telehealth

Roughly two-thirds of Americans end their pregnancies by taking two abortion medications – misoprostol and mifepristone. Because these safe, effective medications can be prescribed via telehealth, without an in-office visit, they are how most ...

Ascendis Pharma: Behind The Stock Surge

Ascendis Pharma: Behind The Stock Surge

11% of Americans Are Currently Taking a GLP-1 Weight Loss Drug Like Wegovy

15 of Americans have ever taken the drugs, up from 6 in 2024.

‘Unprecedented spike’ in new synthetic drugs: UN watchdog

‘Unprecedented spike’ in new synthetic drugs: UN watchdog

Medicare recipients get obesity drug coverage starting July 1

Millions of older Americans in Medicare are about to gain access to obesity drugs for the first time — but that landmark shift may be flying under the radar for many of them. Starting Wednesday, eligible beneficiaries can get obesity drugs through Medicare’s new Bridge demonstration program for a monthly copay of just 50. The []...Click to read more

Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs

Medicare is launching a temporary bridge program that will cover select GLP-1 weight-loss medications from two of the pharmaceutical industry’s largest players. The program will extend coverage to Novo Nordisk’s (CPH: NOVO-B) Wegovy, both in injection and tablet form, marking a significant shift in how the federal health program approaches obesity treatment. Eli Lilly’s (NYSE: [] The post Medicare Launches GLP-1 Bridge Program Covering Novo Nordisk (CPH: NOVO-B) And Eli Lilly (NYSE: LLY) Weight-Loss Drugs appeared first on Foreign Policy Journal.

Medicare will start covering obesity drugs for the first time. Here's what patients should know

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.

Our goal is to bring innovation faster to India: AstraZeneca India-chief

AstraZeneca is focused broadly on oncology (increasingly our largest segment globally and in India); biopharmaceuticals (cardiovascular, renal, respiratory, immunology, and vaccines); and rare diseases.

Countering Common Cancer Conspiracies

The so-called “war on cancer” is not only a miserable failure but has also become a monumental myth perpetuated by the Medical...Click to Keep Reading »

US shoulders disproportionate cost of new medications, report finds

A new Office of Health Policy report reveals Americans shoulder a disproportionate share of prescription drug costs, covering nearly 80 of innovative revenue for new medications.

Number of Americans taking GLP-1s for weight loss hits record high: Survey

A record number of Americans are taking GLP-1 drugs for weight loss, according to a new Gallup survey released Tuesday — a massive increase over the past two years. According to the poll, 11 percent of Americans currently take a GLP-1 medication for weight loss, compared to just 3 percent in 2024. In addition, 15 percent...

Medicare will soon cover costs of weight-loss drugs. Here’s what you need to know

Popular Novo Nordisk and Eli Lilly drugs are included

The Pentagon is doling out erection pills in record numbers while banning gender-affirming care

Newly released data reveals that a record-breaking amount of sex-enhancing medications were prescribed to active duty troops in 2025.

Veterinary Drug Mixed with Fentanyl Is Making Overdoses Harder to Reverse with Naloxone

Medetomidine is being mixed with fentanyl in the U.S. drug supply. Naloxone cannot reverse it. The CDC and ONDCP issued a joint warning. Here's what it means for overdose response.

Afghanistan intensifies fight against synthetic drugs

Officials described synthetic drugs as one of the country's most pressing concerns and said targeted programs have been introduced to combat the problem. The post Afghanistan intensifies fight against synthetic drugs first appeared on Ariana News | Afghanistan News.

Why does cancer seem so common right now? An oncologist explains

Why does cancer seem so common right now? An oncologist explains

What Trump’s DEA Says About Biden Era Fentanyl Fast and Furious Might Surprise You

President Donald Trump’s Drug Enforcement Administration is defending a Biden-era initiative that allowed hundreds of thousands of fentanyl pills into the country for the purpose of building a larger case against drug dealers. This comes after President Trump earlier this week posted a news story which labeled the initiative a possible “Fast and Furious 2.0,”...

UN Report: Huge Increase in Synthetic Drugs Worldwide

UN Report: Huge Increase in Synthetic Drugs Worldwide

Contributor: Mental health care isn't ready for psychedelic side effects

Accelerated FDA approval will invite recklessness. But don't block these important medications. Take steps to prepare.

Ferraris and Shell Companies: Five Charged in Medicare Fraud Schemes

Medicare paid over 10 billion in 2024 for expensive wound coverings called skin substitutes, a sudden spending spike that analysts have called one of the largest examples of waste in the federal health program’s history. The spending was fueled by multiple kickback schemes that enriched both the companies that manufactured skin substitutes and the doctors []

Every euro invested in innovative medicines yields 5.67 euros, EFPIA finds

An analysis carried out across 29 European countries between 2014 and 2024 quantifies, for the first time, the economic and social value of pharmaceutical innovation: 66 billion euros in total benefits, comprising hospital savings and productivity gains

RFK Jr. stacks FDA panel with peptide peddlers as FDA scientists oppose access

Peptide drugs are popular, but FDA scientists warn they're untested, may be harmful.

FDA-approved drug may finally help immunotherapy defeat rare liver cancer

Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping them in nearby fibrous tissue. An FDA-approved drug called AMD3100 freed those T cells to attack the cancer, significantly improving the effectiveness of immunotherapy in tumor samples.

How Big Healthcare Companies Keep Drug Prices High

A handful of large corporations now control medication availability, pricing, and payment for the vast majority of Americans.

What Recent Drug Liability Cases Mean for Consumers

When a medication causes unexpected harm, the consequences can be devastating — physically, emotionally, and

Onitsha Medicine Market hands over fake, expired drugs worth N430m to NAFDAC

By Chimaobi Nwaiwu NNEWI — The leadership of the Ogbo Ogwu Medicine Market in Onitsha, Anambra State, has handed over fake, expired and other unwholesome drugs valued at more than N430 million to the National Agency for Food and Drug Administration and Control (NAFDAC) for destruction, as part of efforts to rid the market of [] The post Onitsha Medicine Market hands over fake, expired drugs worth N430m to NAFDAC appeared first on Vanguard News.